6:03 PM
 | 
Jan 14, 2014
 |  BC Extra  |  Company News

Celgene, NantBioscience in cancer deal

Celgene Corp. (NASDAQ:CELG) partnered with the NantBioscience subsidiary of Patrick Soon-Shiong's NantWorks LLC (Los Angeles, Calif.) to develop a pipeline of cancer drugs using the nanoparticle...

Read the full 119 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >